25 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for Treating Mucosal ... mucoadhesive buccal tablet ... chew, or crush tablet ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Preventing and Treating ... Disease Note: Treatment ... Trypanosomiasis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Preventing and Treating ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Preventing and Treating ... Penicilliosis #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... HCQ treatment would ... risks/benefits in setting ... #COVID19 #Pharmacology ... #Table #Management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... 3 years • Co-testing ... HumanPapillomavirus #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Potential Treatment ... Agents for Treatment ... infection Episode #Pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... for Treating Visceral ... every 21 days Treating ... Leishmaniasis #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Commonly Used Diagnostic Tests for Celiac Disease

Tissue transglutaminase (tTG) IgA antibodies
 - Most reliable noninvasive test
Reflects response to treatment ... Celiac #Disease #Testing ... #Laboratory #Tests ... Diagnosis #Workup #Table
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... for Treating Isospora ... IsosporaBelli #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology